— Know what they know.
Not Investment Advice

CELG-RI Earnings

Bristol-Myers Squibb Company Ce
1W: +18.1% 1M: -12.7% 3M: +29.2% YTD: +62.2% 1Y: +289.2% 3Y: -7.7%
$0.13
+0.02 (+17.45%)
 
Weekly Expected Move ±23.1%
$0 $0 $0 $0 $0
NYSE · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 46 · $263.9M mcap · 2.04B float · 0.0008% daily turnover
Last Earnings 2026-07-30
EPS
$2.04
▲ Beat +27.5%
Revenue
$13.0B
▲ Beat +10.5%
EPS Beat Streak: 3 quarters
Next Earnings 2026-10-29
EPS Estimate
$1.44
Range: $1.44 - $1.44
Revenue Estimate
$11.3B
1 analysts

Estimate vs Actual

Earnings Surprise History

3/5
EPS Beats
5/5
Revenue Beats
60%
EPS Beat Rate
100%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-03 annual 2027-12-31 $6.55 $6.55 — $48,068,771,850 $48,069,070,878
2026-09-03 annual 2026-12-31 $6.93 $6.93 — $49,552,291,955 $49,552,159,319
2026-09-03 annual 2028-12-31 $5.63 $5.63 — $41,928,880,786 $41,930,619,917
2026-09-02 annual 2027-12-31 $6.55 $6.55 — $48,068,760,714 $48,068,771,850
2026-09-02 annual 2026-12-31 $6.93 $6.93 — $49,552,300,923 $49,552,291,955
2026-09-02 annual 2028-12-31 $5.63 $5.63 — $41,928,885,621 $41,928,880,786
2026-08-24 annual 2027-12-31 $6.55 $6.55 — $48,068,760,714 $48,068,760,714
2026-08-24 annual 2026-12-31 $6.93 $6.93 — $49,552,300,923 $49,552,300,923
2026-08-20 annual 2028-12-31 $5.56 $5.63 ▲ 0.07 $41,685,391,510 $41,928,885,621
2026-08-20 annual 2027-12-31 $6.44 $6.55 ▲ 0.11 $47,683,567,682 $48,068,760,714
2026-08-20 annual 2029-12-31 $4.94 $5.08 ▲ 0.14 $37,953,092,857 $37,952,845,680
2026-08-20 annual 2026-12-31 $6.74 $6.93 ▲ 0.19 $48,992,691,087 $49,552,300,923
2026-08-20 annual 2030-12-31 $4.86 $5.00 ▲ 0.14 $37,257,292,857 $37,385,833,747
2026-08-11 annual 2020-12-31 $— $6.40 ▲ 6.40 $— $42,200,417,493
2026-08-11 annual 2019-12-31 $— $4.65 ▲ 4.65 $— $25,325,098,781
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms